Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 37 | 2023 | 66 | 12.680 |
Why?
|
| Obesity, Morbid | 36 | 2023 | 98 | 10.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 213 | 5.200 |
Why?
|
| Weight Loss | 20 | 2022 | 116 | 4.470 |
Why?
|
| Bariatric Surgery | 14 | 2023 | 51 | 4.350 |
Why?
|
| Laparoscopy | 29 | 2022 | 171 | 3.920 |
Why?
|
| Postoperative Complications | 13 | 2023 | 996 | 2.000 |
Why?
|
| Insulin Resistance | 6 | 2018 | 59 | 1.990 |
Why?
|
| Obesity | 8 | 2022 | 304 | 1.950 |
Why?
|
| Gastroesophageal Reflux | 12 | 2012 | 34 | 1.630 |
Why?
|
| Gastrectomy | 7 | 2023 | 34 | 1.460 |
Why?
|
| Middle Aged | 52 | 2022 | 10221 | 1.460 |
Why?
|
| Adipose Tissue | 4 | 2018 | 78 | 1.360 |
Why?
|
| Fundoplication | 10 | 2012 | 20 | 1.310 |
Why?
|
| Female | 56 | 2022 | 16983 | 1.250 |
Why?
|
| Adult | 41 | 2022 | 8944 | 1.250 |
Why?
|
| Humans | 79 | 2023 | 31036 | 1.230 |
Why?
|
| Male | 52 | 2022 | 16478 | 1.190 |
Why?
|
| Prospective Studies | 21 | 2022 | 1896 | 1.170 |
Why?
|
| Body Mass Index | 9 | 2020 | 447 | 1.150 |
Why?
|
| Gastroplasty | 6 | 2019 | 22 | 1.140 |
Why?
|
| Insulin | 4 | 2016 | 97 | 1.090 |
Why?
|
| Esophageal Achalasia | 7 | 2015 | 16 | 1.040 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 161 | 0.920 |
Why?
|
| Bibliometrics | 2 | 2021 | 28 | 0.900 |
Why?
|
| Caloric Restriction | 2 | 2014 | 15 | 0.860 |
Why?
|
| General Surgery | 2 | 2021 | 58 | 0.860 |
Why?
|
| Quality of Life | 7 | 2016 | 697 | 0.850 |
Why?
|
| Treatment Outcome | 22 | 2022 | 3807 | 0.840 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 23 | 0.820 |
Why?
|
| Adiponectin | 2 | 2012 | 9 | 0.810 |
Why?
|
| Omentum | 2 | 2012 | 8 | 0.810 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1936 | 0.800 |
Why?
|
| Biomarkers | 3 | 2020 | 727 | 0.800 |
Why?
|
| Bone Density | 2 | 2020 | 152 | 0.790 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 30 | 0.750 |
Why?
|
| Esophagus | 3 | 2012 | 73 | 0.730 |
Why?
|
| Case-Control Studies | 9 | 2019 | 661 | 0.720 |
Why?
|
| Weight Gain | 2 | 2021 | 69 | 0.710 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 82 | 0.700 |
Why?
|
| Mental Disorders | 1 | 2022 | 145 | 0.700 |
Why?
|
| Osteoclasts | 1 | 2020 | 22 | 0.700 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 42 | 0.680 |
Why?
|
| Protein Precursors | 1 | 2019 | 20 | 0.680 |
Why?
|
| Fractures, Bone | 1 | 2020 | 81 | 0.650 |
Why?
|
| Neoplasms | 1 | 2022 | 261 | 0.640 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 6 | 0.620 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3663 | 0.610 |
Why?
|
| Postprandial Period | 3 | 2016 | 4 | 0.610 |
Why?
|
| Aged | 22 | 2022 | 10063 | 0.530 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 11 | 0.530 |
Why?
|
| Vascular Diseases | 1 | 2016 | 52 | 0.530 |
Why?
|
| Adipocytes | 2 | 2012 | 14 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 60 | 0.510 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.500 |
Why?
|
| Leptin | 2 | 2011 | 24 | 0.500 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 421 | 0.480 |
Why?
|
| Anastomosis, Roux-en-Y | 4 | 2007 | 7 | 0.470 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.460 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 67 | 0.440 |
Why?
|
| Gastric Acid | 1 | 2012 | 9 | 0.430 |
Why?
|
| Postoperative Period | 5 | 2020 | 303 | 0.420 |
Why?
|
| Nomograms | 1 | 2012 | 6 | 0.420 |
Why?
|
| Time Factors | 6 | 2016 | 1678 | 0.410 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 10 | 0.410 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.400 |
Why?
|
| Appetite | 1 | 2011 | 5 | 0.400 |
Why?
|
| Cell Differentiation | 1 | 2012 | 152 | 0.390 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 44 | 0.390 |
Why?
|
| Blood Glucose | 4 | 2014 | 120 | 0.390 |
Why?
|
| Cohort Studies | 5 | 2022 | 2040 | 0.390 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 85 | 0.380 |
Why?
|
| Reoperation | 5 | 2021 | 952 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 174 | 0.370 |
Why?
|
| Catheter Ablation | 4 | 2004 | 107 | 0.330 |
Why?
|
| Bone and Bones | 2 | 2019 | 126 | 0.300 |
Why?
|
| Body Composition | 2 | 2021 | 61 | 0.300 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 45 | 0.300 |
Why?
|
| Adolescent | 7 | 2020 | 2400 | 0.300 |
Why?
|
| Risk Factors | 8 | 2021 | 2580 | 0.290 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 3 | 0.290 |
Why?
|
| United States | 6 | 2022 | 2376 | 0.290 |
Why?
|
| Coronary Disease | 1 | 2007 | 87 | 0.280 |
Why?
|
| Young Adult | 6 | 2020 | 2057 | 0.280 |
Why?
|
| Incidence | 2 | 2022 | 783 | 0.270 |
Why?
|
| Esophagectomy | 1 | 2006 | 24 | 0.270 |
Why?
|
| Laparotomy | 2 | 2021 | 29 | 0.260 |
Why?
|
| Esophagoscopy | 5 | 2005 | 13 | 0.260 |
Why?
|
| Cholecystitis | 3 | 2023 | 10 | 0.260 |
Why?
|
| Hypoglycemia | 2 | 2016 | 14 | 0.250 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 49 | 0.240 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 306 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 11 | 0.240 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 12 | 0.230 |
Why?
|
| Prognosis | 5 | 2020 | 923 | 0.220 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 83 | 0.220 |
Why?
|
| Preoperative Period | 3 | 2019 | 76 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 124 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2004 | 169 | 0.220 |
Why?
|
| Gallstones | 1 | 2023 | 9 | 0.220 |
Why?
|
| Apoptosis | 1 | 2004 | 260 | 0.220 |
Why?
|
| Patient Readmission | 2 | 2021 | 132 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 206 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 274 | 0.210 |
Why?
|
| Energy Metabolism | 2 | 2021 | 53 | 0.210 |
Why?
|
| Fibronectins | 1 | 2022 | 33 | 0.200 |
Why?
|
| Remission Induction | 2 | 2016 | 104 | 0.200 |
Why?
|
| Metabolome | 1 | 2021 | 16 | 0.200 |
Why?
|
| Preoperative Care | 2 | 2016 | 144 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 128 | 0.190 |
Why?
|
| Comorbidity | 2 | 2021 | 507 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 9 | 0.190 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.180 |
Why?
|
| Metronidazole | 1 | 2020 | 9 | 0.180 |
Why?
|
| Levofloxacin | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2021 | 150 | 0.180 |
Why?
|
| Cells, Cultured | 2 | 2012 | 686 | 0.180 |
Why?
|
| Linear Models | 2 | 2014 | 272 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 39 | 0.180 |
Why?
|
| Medicare | 1 | 2021 | 127 | 0.170 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 331 | 0.170 |
Why?
|
| Morbidity | 1 | 2020 | 65 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2020 | 72 | 0.170 |
Why?
|
| Analysis of Variance | 2 | 2019 | 326 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2014 | 715 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 998 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 360 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 344 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 32 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 4 | 0.150 |
Why?
|
| Length of Stay | 2 | 2017 | 339 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 181 | 0.140 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 310 | 0.140 |
Why?
|
| Gene Expression | 1 | 2017 | 239 | 0.140 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 12 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 232 | 0.140 |
Why?
|
| Recurrence | 1 | 2016 | 375 | 0.130 |
Why?
|
| Gastroscopy | 2 | 2004 | 8 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1210 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.120 |
Why?
|
| Amino Acids | 1 | 2014 | 22 | 0.120 |
Why?
|
| Mental Health | 1 | 2016 | 113 | 0.120 |
Why?
|
| Lipids | 1 | 2014 | 38 | 0.120 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.110 |
Why?
|
| Duodenum | 1 | 2013 | 10 | 0.110 |
Why?
|
| Carbon | 1 | 2013 | 7 | 0.110 |
Why?
|
| Choline | 1 | 2013 | 7 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2013 | 31 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2014 | 262 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 551 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 27 | 0.100 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 3 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 3 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 48 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 231 | 0.100 |
Why?
|
| Fasting | 1 | 2011 | 13 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 18 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 134 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 132 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 318 | 0.100 |
Why?
|
| Food | 1 | 2011 | 32 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 505 | 0.100 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 149 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 145 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 329 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 34 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 286 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2009 | 41 | 0.090 |
Why?
|
| Aging | 2 | 2018 | 1729 | 0.090 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 14 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 39 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 5195 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 24 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 143 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 42 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 46 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2006 | 26 | 0.070 |
Why?
|
| Tennessee | 1 | 2006 | 9 | 0.070 |
Why?
|
| Markov Chains | 1 | 2006 | 29 | 0.070 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Operative Time | 2 | 2017 | 85 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 24 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2007 | 80 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 32 | 0.070 |
Why?
|
| Body Weight | 1 | 2006 | 135 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 216 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 52 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 39 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 101 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 72 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 149 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 199 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 333 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Equipment Design | 4 | 2006 | 188 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 194 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 35 | 0.060 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 6 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 410 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 113 | 0.060 |
Why?
|
| Laryngostenosis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 5 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 269 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 370 | 0.050 |
Why?
|
| Bile | 2 | 1993 | 6 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 11 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 503 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 37 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 4713 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 34 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 11 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 18 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 27 | 0.050 |
Why?
|
| Postmenopause | 1 | 2019 | 62 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 353 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 37 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 103 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 14 | 0.040 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 178 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 344 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 420 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 51 | 0.040 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 2 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 2 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 100 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 164 | 0.030 |
Why?
|
| Jejunum | 2 | 2006 | 12 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 508 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 150 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 288 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 15 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 872 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 32 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 21 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 3 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 71 | 0.030 |
Why?
|
| Esthetics | 1 | 2012 | 11 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 19 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 249 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1992 | 17 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 427 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 184 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 28 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 27 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 246 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 586 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 99 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mesocolon | 1 | 2006 | 1 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 5 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 4 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 6 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 6 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 12 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 11 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 109 | 0.020 |
Why?
|
| Hernia | 1 | 2006 | 8 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 14 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 120 | 0.020 |
Why?
|
| Needles | 1 | 2006 | 20 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 14 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 5 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 73 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2005 | 20 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 407 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 41 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 75 | 0.020 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 13 | 0.020 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 19 | 0.020 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2004 | 2 | 0.020 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 27 | 0.020 |
Why?
|
| Cholangiography | 1 | 2004 | 11 | 0.020 |
Why?
|
| Polyvinyls | 1 | 2004 | 1 | 0.020 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.020 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.020 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.020 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 16 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 78 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 135 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 9 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 11 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 499 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 820 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 555 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1134 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 232 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 3 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 41 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 52 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 151 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 695 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 10 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 9 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 12 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 20 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 534 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 408 | 0.010 |
Why?
|